Based on the overexpression and knockdown models, we showed that FTO can improve pancreatic cancer cell resistance to gemcitabine via the FTO-NEDD4-PTEN/PI3K/AKT axis by controlling the cell cycle, thereby influencing cell proliferation. The gene discussed is NEDD4; the disease is familial pancreatic carcinoma.